Accueil   Diary - News   All news EU Lead Factory awards screening programme to CELLIPSE

EU Lead Factory awards screening programme to CELLIPSE

CELLIPSE was awarded an exclusive High Throughput Screening research program to screen the EU Lead Factory’s (ELF) joint compound library on an undisclosed innovative therapeutic target by the Selection Committee on January 19 2015. The kick-off meeting was held in mid-February and the effort, led by Dr Renaud Prudent from CELLIPSE and Dr Helma Rutjes from the ELF partner Pivot Park Screening Centre, is expected to yield its first results within 9 months.

 

Read the press release

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree